Drug Type Monoclonal antibody |
Synonyms BNT 322, BNT-322, BNT322 + [2] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | GE | 24 Oct 2022 | |
Advanced Malignant Solid Neoplasm | Phase 1 | MD | 24 Oct 2022 | |
Advanced Malignant Solid Neoplasm | Phase 1 | ES | 24 Oct 2022 |